Likewise, in HR-positive BC, CD8+ T-cell infiltration has been associated with survival (7), although this is currently under debate since contradictory results have been found for this BC subtype in neoadjuvant (8, 9) and adjuvant (10) settings. This evidence concerns the gene CD8A and breast cancer.